China’s NMPA Greenlights New Measures to Supercharge Innovation in High-End Medical DevicesAI in China China Robotics China SoftwareHealthcare innovation, Medical Devices, NMPA, Regulatory policy June 20, 2025
China’s Innovative Drug Sector is Exploding: Here’s Why Investors Are BuzzingChina Finance Tech in China3SBio, Biotechnology, Bohai Securities, Changshan Pharma, China Securities, Cinda Securities, CSPC Pharmaceutical Group, Everbright Securities, Haichen Pharmaceutical, Healthcare, Huafu Securities, Innovative Drugs, Joincare Pharmaceutical, Lianhe Chemical Technology, Luoxin Pharmaceutical, Medicilon, NMPA, Pfizer, Pharmaceuticals, Shenyang Sansheng, Sunshine Guojian, Xiangcai Securities June 9, 2025
